SCHEMBL2275271

SCHEMBL2275271

COc1cccc(C=CC(=O)Nc2cc(-c3ccccc3)ccc2C(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
TRPA1 O75762 1/20 0.58
MMP1 P03956 2/20 0.58
MMP2 P08253 2/20 0.58
MMP9 P14780 2/20 0.58
TRPM2 O94759 5/20 0.57
LTB4R Q15722 3/20 0.57
ALDH1A1 P00352 4/20 0.55
TP53 P04637 2/20 0.55
CYP3A4 P08684 2/20 0.55
HPGD P15428 2/20 0.55
HIF1A Q16665 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275267 1.00 MEN1 (0.58) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2270270 0.89 MEN1 (0.67) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2270277 0.89 MEN1 (0.67) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2270274 0.89 MEN1 (0.67) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2848732 0.88 TRPA1 (0.76) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2848727 0.88 TRPA1 (0.76) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2276170 0.87 MEN1 (0.61) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2276168 0.87 MEN1 (0.61) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2269338 0.86 TRPM2 (0.75) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL2269335 0.86 TRPM2 (0.75) MEN1KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 MEN1 3105/4885KMT2A 1669/4885MAPT 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.